This inventor holds 2 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Astellas Institute for Regenerative Medicine, Genetether, Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Roy Geoffrey Sargent: Innovator in Nucleic Acid Editing and Regenerative Medicine
Introduction
Roy Geoffrey Sargent is a notable inventor based in San Lorenzo, California. He has made significant contributions to the fields of nucleic acid editing and regenerative medicine. With a total of two patents to his name, Sargent's work is at the forefront of innovative medical technologies.
Latest Patents
Sargent's latest patents include "Modified nucleic acid editing systems for tethering donor DNA." This technology involves a composition that tethers donor DNA to a nuclease, utilizing a nucleic acid that comprises donor DNA and a consensus sequence for a DNA binding domain. The composition also includes a fusion protein that couples a nuclease to a DNA binding domain for binding the consensus sequence. Another significant patent is "Methods of reprogramming animal somatic cells." This invention focuses on methods to obtain mammalian cells and tissues that exhibit gene expression patterns similar to those of developing embryos or fetuses. These methods aim to identify, expand in culture, and formulate mammalian pluripotent stem cells and differentiated cells, offering unique therapeutic strategies for treating degenerative diseases.
Career Highlights
Throughout his career, Sargent has worked with prominent organizations such as Astellas Institute for Regenerative Medicine and Genetether, Inc. His work in these companies has contributed to advancements in regenerative medicine and genetic engineering.
Collaborations
Sargent has collaborated with notable professionals in his field, including Michael D. West and Karen B. Chapman. These collaborations have further enhanced his research and development efforts.
Conclusion
Roy Geoffrey Sargent is a distinguished inventor whose work in nucleic acid editing and regenerative medicine has the potential to revolutionize therapeutic strategies for various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile